Top Price Market
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

Top Price Market

Politics

Chip Roy unveils bill to let Americans sue COVID-19 vaccine makers over injury, negative effects

by March 6, 2024
March 6, 2024
Chip Roy unveils bill to let Americans sue COVID-19 vaccine makers over injury, negative effects

Rep. Chip Roy, R-Texas, is unveiling a new bill on Tuesday that would allow Americans to sue COVID-19 vaccine makers over adverse health effects allegedly caused by the shot.

The Let Injured Americans Be Legally Empowered (LIABLE) Act is aimed at wiping away COVID-19 vaccine manufacturers’ statutory protections, opening them up to civil lawsuits.

A summary of the bill obtained by Fox News Digital said, ‘The LIABLE Act will allow Americans who took vaccines that were misleadingly promoted and forced onto many Americans via federal mandates to pursue civil litigation for their injuries. These vaccines were given emergency use authorization unilaterally and did not go through the normal FDA approval process.’

Currently, manufacturers and health care providers responsible for distributing COVID-19 vaccines are mostly immune from civil lawsuits, even if those seeking money damages have medical proof of their vaccine-related injuries.

That’s because the Public Readiness and Emergency Preparedness (PREP) Act of 2005 limits liability for the manufacturing, development and distribution of medical countermeasures related to a public health emergency.

The PREP Act also created the Countermeasures Injury Compensation Program (CICP), which has a one-year statute of limitations and only provides compensation in the event of death or serious injury. According to Roy, CICP has compensated people just 11 times despite thousands of claims lodged.

‘Millions of Americans were forced to take a COVID-19 shot out of fear of losing their livelihoods and under false pretenses,’ Roy told Fox News Digital. ‘Many have faced injury from the vaccine, but few have been afforded…recourse. To date, a mere 11 injury claims have been paid out despite nearly 700 million doses of the vaccine having been administered.’

Despite the public health emergency declaration for the COVID-19 pandemic expiring last May, PREP Act liability protections for the vaccine are expected to mostly last through the end of this year, according to a report by the Congressional Research Service. 

Roy’s LIABLE Act would allow Americans claiming to be injured from the vaccine to retroactively sue manufacturers despite the aforementioned protections.

While credited with saving countless lives during the pandemic, the COVID-19 vaccine has also been blamed by critics for side effects such as blood clots, strokes and even sudden death. 

Many of these cases still require further study, but it’s a trend that’s alarmed Republican lawmakers who have long said mandating the COVID-19 vaccine is a violation of Americans’ right to privacy.

Andrew Powaleny, PhRMA spokesperson, criticized the bill in a statement to Fox News Digital.

‘COVID-19 has been a reminder of why we need safe and effective vaccines. All vaccines, including those for COVID-19, are subject to a rigorous safety and efficacy review process and post-market monitoring. By upending the existing liability framework manufacturers rely upon to provide predictable vaccine development, our ability to address future public health threats will be at risk,’ he said.

Roy has led the charge against those vaccine mandates, including leading efforts to roll back COVID-19 vaccine mandates in the U.S. military.

His latest bill has at least a dozen House GOP co-sponsors.

Fox News Digital reached out to the Department of Health and Human Services for comment.

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Sen Hawley wants Biden to hike tariffs on Chinese energy imports
next post
Sen Menendez charged with obstruction of justice in another superseding indictment

You may also like

What we know about the Trump administration’s plans...

Democrats don’t get a do-over just because of...

Trump pulls security clearance of 51 national security...

America’s Golden Dome can’t wait

From CDC to labor secretary: See Trump’s top...

Senate GOP lawmakers bash $1.66 trillion Johnson-Schumer budget...

Rubio demands answers with 2 more Americans reportedly...

Speaker Johnson says House will match Trump’s pace...

Donald Trump Jr ally Sergio Gor offered top...

Fox News Poll: Support for Haley doubles in...

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • NorthStar Gaming Announces Results of Annual Meeting and Grant of Equity Incentive...

    • Allied Critical Metals Commences 5,000 Metre Drill Program at its Borralha Tungsten Project

    • SOURCE ROCK ROYALTIES ANNOUNCES FIRST QUARTER 2025 RESULTS

    • Polish conservative Karol Nawrocki wins presidential election to succeed Duda

    • Will the Trump Cabinet undo Musk’s DOGE legacy now that he’s gone?

    Categories

    • Business (1,672)
    • Investing (4,998)
    • Politics (7,863)
    • Uncategorized (2)
    • World (6,379)
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Disclaimer: toppricemarket.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 toppricemarket.com | All Rights Reserved


    Back To Top